nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—SLC36A2—gonad—hematologic cancer	0.0595	0.45	CbGeAlD
Cycloserine—SLC36A2—testis—hematologic cancer	0.0429	0.324	CbGeAlD
Cycloserine—DDC—Biogenic Amine Synthesis—HDC—hematologic cancer	0.0196	0.0853	CbGpPWpGaD
Cycloserine—DDC—lung—hematologic cancer	0.0114	0.0859	CbGeAlD
Cycloserine—DDC—testis—hematologic cancer	0.0107	0.0811	CbGeAlD
Cycloserine—SLC36A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hematologic cancer	0.0106	0.0462	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—RET—hematologic cancer	0.00874	0.0381	CbGpPWpGaD
Cycloserine—DDC—lymph node—hematologic cancer	0.00777	0.0588	CbGeAlD
Cycloserine—DDC—Dopamine metabolism—NQO1—hematologic cancer	0.00774	0.0338	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—UCHL1—hematologic cancer	0.00723	0.0315	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—SNCA—hematologic cancer	0.00632	0.0276	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.00531	0.0232	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.00523	0.0228	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.00474	0.0207	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00383	0.0167	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—CASP7—hematologic cancer	0.00368	0.0161	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.00363	0.0158	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00356	0.0155	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—FTCD—hematologic cancer	0.00341	0.0149	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PER3—hematologic cancer	0.00324	0.0141	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.00313	0.0137	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—CYCS—hematologic cancer	0.00311	0.0135	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.00296	0.0129	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.0029	0.0127	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—TCF3—hematologic cancer	0.00287	0.0125	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.00285	0.0124	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PER2—hematologic cancer	0.00275	0.012	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CRY2—hematologic cancer	0.00275	0.012	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CRY1—hematologic cancer	0.00275	0.012	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—ASNS—hematologic cancer	0.00273	0.0119	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.0027	0.0118	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—GATA2—hematologic cancer	0.00264	0.0115	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—HDC—hematologic cancer	0.00259	0.0113	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.00254	0.0111	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.00241	0.0105	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—ID3—hematologic cancer	0.00234	0.0102	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—RET—hematologic cancer	0.00234	0.0102	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.0022	0.0096	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.0022	0.0096	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.0022	0.0096	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—KMT2A—hematologic cancer	0.00209	0.0091	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PER1—hematologic cancer	0.00209	0.0091	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—MAPK14—hematologic cancer	0.00201	0.00879	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—MTAP—hematologic cancer	0.00201	0.00878	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.00198	0.00864	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—TOP1—hematologic cancer	0.00191	0.00832	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—ID2—hematologic cancer	0.00186	0.00811	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.00174	0.00759	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	0.00165	0.00718	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	0.00159	0.00695	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.00159	0.00694	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	0.00158	0.00688	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—MYB—hematologic cancer	0.00152	0.00662	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.0015	0.00655	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—ARNTL—hematologic cancer	0.00149	0.00648	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.00146	0.00636	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.00145	0.00631	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.00142	0.00619	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—STAT3—hematologic cancer	0.00134	0.00583	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—CASP3—hematologic cancer	0.00132	0.00574	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL13—hematologic cancer	0.0013	0.00567	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.00126	0.00551	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—JUND—hematologic cancer	0.00126	0.00551	CbGpPWpGaD
Cycloserine—DDC—Tryptophan metabolism—MDM2—hematologic cancer	0.00126	0.00551	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—TGFB1—hematologic cancer	0.00124	0.0054	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—GATA3—hematologic cancer	0.00117	0.00511	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—MTR—hematologic cancer	0.00116	0.00504	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CST3—hematologic cancer	0.00113	0.00495	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	0.00109	0.00475	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PML—hematologic cancer	0.00107	0.00466	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.00106	0.00463	CbGpPWpGaD
Cycloserine—Confusional state—Bleomycin—hematologic cancer	0.00103	0.00161	CcSEcCtD
Cycloserine—Hypersensitivity—Dasatinib—hematologic cancer	0.00103	0.00161	CcSEcCtD
Cycloserine—Hypersensitivity—Bexarotene—hematologic cancer	0.00103	0.00161	CcSEcCtD
Cycloserine—Rash—Idarubicin—hematologic cancer	0.00102	0.0016	CcSEcCtD
Cycloserine—Dermatitis—Idarubicin—hematologic cancer	0.00102	0.0016	CcSEcCtD
Cycloserine—Hypersensitivity—Fludarabine—hematologic cancer	0.00102	0.0016	CcSEcCtD
Cycloserine—Tremor—Carmustine—hematologic cancer	0.00102	0.0016	CcSEcCtD
Cycloserine—Vertigo—Thalidomide—hematologic cancer	0.00102	0.0016	CcSEcCtD
Cycloserine—Headache—Idarubicin—hematologic cancer	0.00102	0.00159	CcSEcCtD
Cycloserine—Convulsion—Thiotepa—hematologic cancer	0.00102	0.00159	CcSEcCtD
Cycloserine—Tremor—Alitretinoin—hematologic cancer	0.00101	0.00158	CcSEcCtD
Cycloserine—Osteoarthritis—Prednisone—hematologic cancer	0.001	0.00157	CcSEcCtD
Cycloserine—Paraesthesia—Lenalidomide—hematologic cancer	0.001	0.00157	CcSEcCtD
Cycloserine—Rash—Teniposide—hematologic cancer	0.000996	0.00156	CcSEcCtD
Cycloserine—Dermatitis—Teniposide—hematologic cancer	0.000995	0.00156	CcSEcCtD
Cycloserine—Feeling abnormal—Vinblastine—hematologic cancer	0.000993	0.00156	CcSEcCtD
Cycloserine—Somnolence—Lenalidomide—hematologic cancer	0.000991	0.00155	CcSEcCtD
Cycloserine—Headache—Teniposide—hematologic cancer	0.00099	0.00155	CcSEcCtD
Cycloserine—Coma—Epirubicin—hematologic cancer	0.000987	0.00155	CcSEcCtD
Cycloserine—Convulsion—Thalidomide—hematologic cancer	0.000982	0.00154	CcSEcCtD
Cycloserine—Psychotic disorder—Prednisone—hematologic cancer	0.000979	0.00153	CcSEcCtD
Cycloserine—Somnolence—Hydroxyurea—hematologic cancer	0.000977	0.00153	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—TOP2A—hematologic cancer	0.000976	0.00426	CbGpPWpGaD
Cycloserine—Hypersensitivity—Chlorambucil—hematologic cancer	0.000969	0.00152	CcSEcCtD
Cycloserine—Confusional state—Thiotepa—hematologic cancer	0.000965	0.00151	CcSEcCtD
Cycloserine—Vertigo—Ifosfamide—hematologic cancer	0.000958	0.0015	CcSEcCtD
Cycloserine—Hypersensitivity—Nilotinib—hematologic cancer	0.000948	0.00148	CcSEcCtD
Cycloserine—Convulsion—Carmustine—hematologic cancer	0.000944	0.00148	CcSEcCtD
Cycloserine—Hypersensitivity—Imatinib—hematologic cancer	0.000943	0.00148	CcSEcCtD
Cycloserine—Convulsion—Alitretinoin—hematologic cancer	0.000935	0.00146	CcSEcCtD
Cycloserine—Vertigo—Vincristine—hematologic cancer	0.000934	0.00146	CcSEcCtD
Cycloserine—Confusional state—Thalidomide—hematologic cancer	0.000933	0.00146	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—AR—hematologic cancer	0.00093	0.00406	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—EZH2—hematologic cancer	0.000927	0.00404	CbGpPWpGaD
Cycloserine—Hypersensitivity—Cladribine—hematologic cancer	0.000926	0.00145	CcSEcCtD
Cycloserine—Convulsion—Ifosfamide—hematologic cancer	0.000924	0.00145	CcSEcCtD
Cycloserine—Rash—Busulfan—hematologic cancer	0.000923	0.00145	CcSEcCtD
Cycloserine—Dermatitis—Busulfan—hematologic cancer	0.000922	0.00144	CcSEcCtD
Cycloserine—Paraesthesia—Bortezomib—hematologic cancer	0.000921	0.00144	CcSEcCtD
Cycloserine—Feeling abnormal—Lenalidomide—hematologic cancer	0.000919	0.00144	CcSEcCtD
Cycloserine—Headache—Busulfan—hematologic cancer	0.000917	0.00144	CcSEcCtD
Cycloserine—Paraesthesia—Bleomycin—hematologic cancer	0.000914	0.00143	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—NQO1—hematologic cancer	0.000914	0.00398	CbGpPWpGaD
Cycloserine—Coma—Doxorubicin—hematologic cancer	0.000913	0.00143	CcSEcCtD
Cycloserine—Vertigo—Irinotecan—hematologic cancer	0.00091	0.00142	CcSEcCtD
Cycloserine—Feeling abnormal—Hydroxyurea—hematologic cancer	0.000906	0.00142	CcSEcCtD
Cycloserine—Convulsion—Vincristine—hematologic cancer	0.000901	0.00141	CcSEcCtD
Cycloserine—Paraesthesia—Vinorelbine—hematologic cancer	0.0009	0.00141	CcSEcCtD
Cycloserine—Confusional state—Carmustine—hematologic cancer	0.000896	0.0014	CcSEcCtD
Cycloserine—Rash—Procarbazine—hematologic cancer	0.000896	0.0014	CcSEcCtD
Cycloserine—Dermatitis—Procarbazine—hematologic cancer	0.000895	0.0014	CcSEcCtD
Cycloserine—Headache—Procarbazine—hematologic cancer	0.00089	0.00139	CcSEcCtD
Cycloserine—Hypersensitivity—Vinblastine—hematologic cancer	0.000888	0.00139	CcSEcCtD
Cycloserine—Confusional state—Alitretinoin—hematologic cancer	0.000888	0.00139	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000885	0.00386	CbGpPWpGaD
Cycloserine—Rash—Dasatinib—hematologic cancer	0.000878	0.00138	CcSEcCtD
Cycloserine—Rash—Bexarotene—hematologic cancer	0.000878	0.00138	CcSEcCtD
Cycloserine—Confusional state—Ifosfamide—hematologic cancer	0.000877	0.00137	CcSEcCtD
Cycloserine—Dermatitis—Dasatinib—hematologic cancer	0.000877	0.00137	CcSEcCtD
Cycloserine—Dermatitis—Bexarotene—hematologic cancer	0.000877	0.00137	CcSEcCtD
Cycloserine—Convulsion—Mitoxantrone—hematologic cancer	0.000877	0.00137	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—HDAC2—hematologic cancer	0.000876	0.00382	CbGpPWpGaD
Cycloserine—Rash—Fludarabine—hematologic cancer	0.000876	0.00137	CcSEcCtD
Cycloserine—Dermatitis—Fludarabine—hematologic cancer	0.000875	0.00137	CcSEcCtD
Cycloserine—Headache—Dasatinib—hematologic cancer	0.000872	0.00137	CcSEcCtD
Cycloserine—Headache—Bexarotene—hematologic cancer	0.000872	0.00137	CcSEcCtD
Cycloserine—Headache—Fludarabine—hematologic cancer	0.00087	0.00136	CcSEcCtD
Cycloserine—Cardiac failure congestive—Epirubicin—hematologic cancer	0.000864	0.00135	CcSEcCtD
Cycloserine—Tremor—Cisplatin—hematologic cancer	0.000861	0.00135	CcSEcCtD
Cycloserine—Paraesthesia—Thiotepa—hematologic cancer	0.000859	0.00135	CcSEcCtD
Cycloserine—Somnolence—Thiotepa—hematologic cancer	0.000851	0.00133	CcSEcCtD
Cycloserine—Feeling abnormal—Bortezomib—hematologic cancer	0.000845	0.00132	CcSEcCtD
Cycloserine—Hypersensitivity—Melphalan—hematologic cancer	0.000845	0.00132	CcSEcCtD
Cycloserine—Feeling abnormal—Bleomycin—hematologic cancer	0.000839	0.00131	CcSEcCtD
Cycloserine—Osteoarthritis—Methotrexate—hematologic cancer	0.000838	0.00131	CcSEcCtD
Cycloserine—Confusional state—Mitoxantrone—hematologic cancer	0.000833	0.0013	CcSEcCtD
Cycloserine—Confusional state—Irinotecan—hematologic cancer	0.000833	0.0013	CcSEcCtD
Cycloserine—Paraesthesia—Thalidomide—hematologic cancer	0.000831	0.0013	CcSEcCtD
Cycloserine—Feeling abnormal—Vinorelbine—hematologic cancer	0.000826	0.00129	CcSEcCtD
Cycloserine—Somnolence—Thalidomide—hematologic cancer	0.000823	0.00129	CcSEcCtD
Cycloserine—Hypersensitivity—Lenalidomide—hematologic cancer	0.000821	0.00129	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HES1—hematologic cancer	0.000818	0.00357	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL10—hematologic cancer	0.000813	0.00355	CbGpPWpGaD
Cycloserine—Rash—Nilotinib—hematologic cancer	0.000811	0.00127	CcSEcCtD
Cycloserine—Dermatitis—Nilotinib—hematologic cancer	0.00081	0.00127	CcSEcCtD
Cycloserine—Hypersensitivity—Hydroxyurea—hematologic cancer	0.00081	0.00127	CcSEcCtD
Cycloserine—Rash—Imatinib—hematologic cancer	0.000807	0.00126	CcSEcCtD
Cycloserine—Headache—Nilotinib—hematologic cancer	0.000806	0.00126	CcSEcCtD
Cycloserine—Dermatitis—Imatinib—hematologic cancer	0.000806	0.00126	CcSEcCtD
Cycloserine—Headache—Imatinib—hematologic cancer	0.000801	0.00126	CcSEcCtD
Cycloserine—Cardiac failure congestive—Doxorubicin—hematologic cancer	0.0008	0.00125	CcSEcCtD
Cycloserine—Paraesthesia—Carmustine—hematologic cancer	0.000798	0.00125	CcSEcCtD
Cycloserine—Convulsion—Cisplatin—hematologic cancer	0.000796	0.00125	CcSEcCtD
Cycloserine—Rash—Cladribine—hematologic cancer	0.000793	0.00124	CcSEcCtD
Cycloserine—Dermatitis—Cladribine—hematologic cancer	0.000792	0.00124	CcSEcCtD
Cycloserine—Paraesthesia—Alitretinoin—hematologic cancer	0.000791	0.00124	CcSEcCtD
Cycloserine—Somnolence—Carmustine—hematologic cancer	0.00079	0.00124	CcSEcCtD
Cycloserine—Feeling abnormal—Thiotepa—hematologic cancer	0.000788	0.00123	CcSEcCtD
Cycloserine—Headache—Cladribine—hematologic cancer	0.000787	0.00123	CcSEcCtD
Cycloserine—Osteoarthritis—Epirubicin—hematologic cancer	0.000784	0.00123	CcSEcCtD
Cycloserine—Somnolence—Alitretinoin—hematologic cancer	0.000783	0.00123	CcSEcCtD
Cycloserine—Paraesthesia—Ifosfamide—hematologic cancer	0.000781	0.00122	CcSEcCtD
Cycloserine—Somnolence—Ifosfamide—hematologic cancer	0.000774	0.00121	CcSEcCtD
Cycloserine—Feeling abnormal—Thalidomide—hematologic cancer	0.000763	0.00119	CcSEcCtD
Cycloserine—Paraesthesia—Vincristine—hematologic cancer	0.000762	0.00119	CcSEcCtD
Cycloserine—Vertigo—Etoposide—hematologic cancer	0.000757	0.00119	CcSEcCtD
Cycloserine—Hypersensitivity—Bortezomib—hematologic cancer	0.000756	0.00118	CcSEcCtD
Cycloserine—Headache—Vinblastine—hematologic cancer	0.000755	0.00118	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	0.000752	0.00328	CbGpPWpGaD
Cycloserine—Hypersensitivity—Bleomycin—hematologic cancer	0.00075	0.00117	CcSEcCtD
Cycloserine—Vertigo—Prednisolone—hematologic cancer	0.000746	0.00117	CcSEcCtD
Cycloserine—Paraesthesia—Mitoxantrone—hematologic cancer	0.000742	0.00116	CcSEcCtD
Cycloserine—Paraesthesia—Irinotecan—hematologic cancer	0.000742	0.00116	CcSEcCtD
Cycloserine—Hypersensitivity—Vinorelbine—hematologic cancer	0.000738	0.00116	CcSEcCtD
Cycloserine—Somnolence—Mitoxantrone—hematologic cancer	0.000735	0.00115	CcSEcCtD
Cycloserine—Somnolence—Irinotecan—hematologic cancer	0.000735	0.00115	CcSEcCtD
Cycloserine—Feeling abnormal—Carmustine—hematologic cancer	0.000732	0.00115	CcSEcCtD
Cycloserine—Convulsion—Etoposide—hematologic cancer	0.00073	0.00114	CcSEcCtD
Cycloserine—Feeling abnormal—Alitretinoin—hematologic cancer	0.000726	0.00114	CcSEcCtD
Cycloserine—Osteoarthritis—Doxorubicin—hematologic cancer	0.000725	0.00114	CcSEcCtD
Cycloserine—Rash—Melphalan—hematologic cancer	0.000723	0.00113	CcSEcCtD
Cycloserine—Paraesthesia—Gemcitabine—hematologic cancer	0.000723	0.00113	CcSEcCtD
Cycloserine—Dermatitis—Melphalan—hematologic cancer	0.000722	0.00113	CcSEcCtD
Cycloserine—Convulsion—Prednisolone—hematologic cancer	0.00072	0.00113	CcSEcCtD
Cycloserine—Feeling abnormal—Ifosfamide—hematologic cancer	0.000717	0.00112	CcSEcCtD
Cycloserine—Somnolence—Gemcitabine—hematologic cancer	0.000715	0.00112	CcSEcCtD
Cycloserine—Hypersensitivity—Thiotepa—hematologic cancer	0.000705	0.0011	CcSEcCtD
Cycloserine—Rash—Lenalidomide—hematologic cancer	0.000703	0.0011	CcSEcCtD
Cycloserine—Dermatitis—Lenalidomide—hematologic cancer	0.000702	0.0011	CcSEcCtD
Cycloserine—Headache—Lenalidomide—hematologic cancer	0.000698	0.00109	CcSEcCtD
Cycloserine—Rash—Hydroxyurea—hematologic cancer	0.000693	0.00109	CcSEcCtD
Cycloserine—Confusional state—Etoposide—hematologic cancer	0.000693	0.00109	CcSEcCtD
Cycloserine—Dermatitis—Hydroxyurea—hematologic cancer	0.000693	0.00108	CcSEcCtD
Cycloserine—Headache—Hydroxyurea—hematologic cancer	0.000689	0.00108	CcSEcCtD
Cycloserine—Vertigo—Triamcinolone—hematologic cancer	0.000686	0.00107	CcSEcCtD
Cycloserine—Hypersensitivity—Thalidomide—hematologic cancer	0.000682	0.00107	CcSEcCtD
Cycloserine—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000681	0.00107	CcSEcCtD
Cycloserine—Feeling abnormal—Irinotecan—hematologic cancer	0.000681	0.00107	CcSEcCtD
Cycloserine—Paraesthesia—Cisplatin—hematologic cancer	0.000674	0.00106	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—NCOR1—hematologic cancer	0.000664	0.00289	CbGpPWpGaD
Cycloserine—Feeling abnormal—Gemcitabine—hematologic cancer	0.000663	0.00104	CcSEcCtD
Cycloserine—Convulsion—Triamcinolone—hematologic cancer	0.000662	0.00104	CcSEcCtD
Cycloserine—Hypersensitivity—Carmustine—hematologic cancer	0.000655	0.00103	CcSEcCtD
Cycloserine—Hypersensitivity—Alitretinoin—hematologic cancer	0.000649	0.00102	CcSEcCtD
Cycloserine—Rash—Bortezomib—hematologic cancer	0.000647	0.00101	CcSEcCtD
Cycloserine—Dermatitis—Bortezomib—hematologic cancer	0.000646	0.00101	CcSEcCtD
Cycloserine—Drowsiness—Methotrexate—hematologic cancer	0.000645	0.00101	CcSEcCtD
Cycloserine—Headache—Bortezomib—hematologic cancer	0.000643	0.00101	CcSEcCtD
Cycloserine—Rash—Bleomycin—hematologic cancer	0.000642	0.00101	CcSEcCtD
Cycloserine—Dermatitis—Bleomycin—hematologic cancer	0.000641	0.001	CcSEcCtD
Cycloserine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000641	0.001	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—PRKCG—hematologic cancer	0.000633	0.00276	CbGpPWpGaD
Cycloserine—Rash—Vinorelbine—hematologic cancer	0.000632	0.000989	CcSEcCtD
Cycloserine—Dermatitis—Vinorelbine—hematologic cancer	0.000631	0.000988	CcSEcCtD
Cycloserine—Headache—Vinorelbine—hematologic cancer	0.000628	0.000983	CcSEcCtD
Cycloserine—DDC—Metabolism—FTCD—hematologic cancer	0.000627	0.00273	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GMPS—hematologic cancer	0.000627	0.00273	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PHYH—hematologic cancer	0.000627	0.00273	CbGpPWpGaD
Cycloserine—Hypersensitivity—Vincristine—hematologic cancer	0.000625	0.000979	CcSEcCtD
Cycloserine—Vertigo—Dexamethasone—hematologic cancer	0.000623	0.000975	CcSEcCtD
Cycloserine—Vertigo—Betamethasone—hematologic cancer	0.000623	0.000975	CcSEcCtD
Cycloserine—Feeling abnormal—Cisplatin—hematologic cancer	0.000618	0.000968	CcSEcCtD
Cycloserine—Paraesthesia—Etoposide—hematologic cancer	0.000617	0.000967	CcSEcCtD
Cycloserine—Somnolence—Etoposide—hematologic cancer	0.000611	0.000957	CcSEcCtD
Cycloserine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000609	0.000953	CcSEcCtD
Cycloserine—Hypersensitivity—Irinotecan—hematologic cancer	0.000609	0.000953	CcSEcCtD
Cycloserine—Paraesthesia—Prednisolone—hematologic cancer	0.000609	0.000953	CcSEcCtD
Cycloserine—Drowsiness—Epirubicin—hematologic cancer	0.000604	0.000946	CcSEcCtD
Cycloserine—Rash—Thiotepa—hematologic cancer	0.000603	0.000945	CcSEcCtD
Cycloserine—Dermatitis—Thiotepa—hematologic cancer	0.000603	0.000944	CcSEcCtD
Cycloserine—Convulsion—Betamethasone—hematologic cancer	0.0006	0.000941	CcSEcCtD
Cycloserine—Convulsion—Dexamethasone—hematologic cancer	0.0006	0.000941	CcSEcCtD
Cycloserine—Headache—Thiotepa—hematologic cancer	0.000599	0.000939	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—FAS—hematologic cancer	0.000595	0.00259	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000592	0.00258	CbGpPWpGaD
Cycloserine—Rash—Thalidomide—hematologic cancer	0.000583	0.000914	CcSEcCtD
Cycloserine—Dermatitis—Thalidomide—hematologic cancer	0.000583	0.000913	CcSEcCtD
Cycloserine—Headache—Thalidomide—hematologic cancer	0.00058	0.000908	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—CREB1—hematologic cancer	0.000575	0.00251	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SMPD3—hematologic cancer	0.000573	0.0025	CbGpPWpGaD
Cycloserine—Feeling abnormal—Etoposide—hematologic cancer	0.000566	0.000887	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL6R—hematologic cancer	0.000561	0.00244	CbGpPWpGaD
Cycloserine—Rash—Carmustine—hematologic cancer	0.00056	0.000878	CcSEcCtD
Cycloserine—Dermatitis—Carmustine—hematologic cancer	0.00056	0.000877	CcSEcCtD
Cycloserine—Paraesthesia—Triamcinolone—hematologic cancer	0.00056	0.000877	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	0.00056	0.00244	CbGpPWpGaD
Cycloserine—Drowsiness—Doxorubicin—hematologic cancer	0.000559	0.000875	CcSEcCtD
Cycloserine—Feeling abnormal—Prednisolone—hematologic cancer	0.000559	0.000875	CcSEcCtD
Cycloserine—Headache—Carmustine—hematologic cancer	0.000557	0.000872	CcSEcCtD
Cycloserine—Rash—Alitretinoin—hematologic cancer	0.000555	0.00087	CcSEcCtD
Cycloserine—Dermatitis—Alitretinoin—hematologic cancer	0.000555	0.000869	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000554	0.00241	CbGpPWpGaD
Cycloserine—Hypersensitivity—Cisplatin—hematologic cancer	0.000553	0.000866	CcSEcCtD
Cycloserine—Headache—Alitretinoin—hematologic cancer	0.000552	0.000864	CcSEcCtD
Cycloserine—Rash—Ifosfamide—hematologic cancer	0.000549	0.000859	CcSEcCtD
Cycloserine—Dermatitis—Ifosfamide—hematologic cancer	0.000548	0.000859	CcSEcCtD
Cycloserine—Vertigo—Prednisone—hematologic cancer	0.000542	0.000849	CcSEcCtD
Cycloserine—Rash—Vincristine—hematologic cancer	0.000535	0.000838	CcSEcCtD
Cycloserine—Dermatitis—Vincristine—hematologic cancer	0.000534	0.000837	CcSEcCtD
Cycloserine—Headache—Vincristine—hematologic cancer	0.000531	0.000832	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—CDK4—hematologic cancer	0.000524	0.00228	CbGpPWpGaD
Cycloserine—Convulsion—Prednisone—hematologic cancer	0.000523	0.000819	CcSEcCtD
Cycloserine—Rash—Irinotecan—hematologic cancer	0.000521	0.000816	CcSEcCtD
Cycloserine—Rash—Mitoxantrone—hematologic cancer	0.000521	0.000816	CcSEcCtD
Cycloserine—Dermatitis—Mitoxantrone—hematologic cancer	0.00052	0.000815	CcSEcCtD
Cycloserine—Dermatitis—Irinotecan—hematologic cancer	0.00052	0.000815	CcSEcCtD
Cycloserine—Headache—Mitoxantrone—hematologic cancer	0.000518	0.000811	CcSEcCtD
Cycloserine—Headache—Irinotecan—hematologic cancer	0.000518	0.000811	CcSEcCtD
Cycloserine—Feeling abnormal—Triamcinolone—hematologic cancer	0.000514	0.000805	CcSEcCtD
Cycloserine—Paraesthesia—Dexamethasone—hematologic cancer	0.000508	0.000796	CcSEcCtD
Cycloserine—Paraesthesia—Betamethasone—hematologic cancer	0.000508	0.000796	CcSEcCtD
Cycloserine—Rash—Gemcitabine—hematologic cancer	0.000507	0.000795	CcSEcCtD
Cycloserine—Dermatitis—Gemcitabine—hematologic cancer	0.000507	0.000794	CcSEcCtD
Cycloserine—Hypersensitivity—Etoposide—hematologic cancer	0.000506	0.000793	CcSEcCtD
Cycloserine—Headache—Gemcitabine—hematologic cancer	0.000504	0.00079	CcSEcCtD
Cycloserine—DDC—Metabolism—B3GAT1—hematologic cancer	0.000501	0.00219	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ASNS—hematologic cancer	0.000501	0.00219	CbGpPWpGaD
Cycloserine—DDC—Metabolism—DCK—hematologic cancer	0.000501	0.00219	CbGpPWpGaD
Cycloserine—Hypersensitivity—Prednisolone—hematologic cancer	0.000499	0.000782	CcSEcCtD
Cycloserine—DDC—Metabolism—HDC—hematologic cancer	0.000475	0.00207	CbGpPWpGaD
Cycloserine—Rash—Cisplatin—hematologic cancer	0.000473	0.000741	CcSEcCtD
Cycloserine—Dermatitis—Cisplatin—hematologic cancer	0.000473	0.00074	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—CREB1—hematologic cancer	0.000469	0.00205	CbGpPWpGaD
Cycloserine—Feeling abnormal—Dexamethasone—hematologic cancer	0.000466	0.00073	CcSEcCtD
Cycloserine—Feeling abnormal—Betamethasone—hematologic cancer	0.000466	0.00073	CcSEcCtD
Cycloserine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000459	0.000719	CcSEcCtD
Cycloserine—Vertigo—Methotrexate—hematologic cancer	0.000453	0.00071	CcSEcCtD
Cycloserine—Paraesthesia—Prednisone—hematologic cancer	0.000442	0.000693	CcSEcCtD
Cycloserine—Convulsion—Methotrexate—hematologic cancer	0.000437	0.000685	CcSEcCtD
Cycloserine—DDC—Metabolism—CDA—hematologic cancer	0.000435	0.0019	CbGpPWpGaD
Cycloserine—Rash—Etoposide—hematologic cancer	0.000433	0.000679	CcSEcCtD
Cycloserine—Dermatitis—Etoposide—hematologic cancer	0.000433	0.000678	CcSEcCtD
Cycloserine—Headache—Etoposide—hematologic cancer	0.000431	0.000674	CcSEcCtD
Cycloserine—Rash—Prednisolone—hematologic cancer	0.000427	0.000669	CcSEcCtD
Cycloserine—Dermatitis—Prednisolone—hematologic cancer	0.000427	0.000669	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL1B—hematologic cancer	0.000426	0.00186	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CASP3—hematologic cancer	0.000425	0.00186	CbGpPWpGaD
Cycloserine—Headache—Prednisolone—hematologic cancer	0.000425	0.000665	CcSEcCtD
Cycloserine—Vertigo—Epirubicin—hematologic cancer	0.000424	0.000664	CcSEcCtD
Cycloserine—DDC—Metabolism—PC—hematologic cancer	0.000418	0.00182	CbGpPWpGaD
Cycloserine—Confusional state—Methotrexate—hematologic cancer	0.000415	0.00065	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—JUN—hematologic cancer	0.000413	0.0018	CbGpPWpGaD
Cycloserine—Convulsion—Epirubicin—hematologic cancer	0.000409	0.000641	CcSEcCtD
Cycloserine—Feeling abnormal—Prednisone—hematologic cancer	0.000406	0.000636	CcSEcCtD
Cycloserine—DDC—Metabolism—GBA—hematologic cancer	0.000404	0.00176	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC35B2—hematologic cancer	0.000404	0.00176	CbGpPWpGaD
Cycloserine—Rash—Triamcinolone—hematologic cancer	0.000393	0.000616	CcSEcCtD
Cycloserine—Dermatitis—Triamcinolone—hematologic cancer	0.000393	0.000615	CcSEcCtD
Cycloserine—Vertigo—Doxorubicin—hematologic cancer	0.000392	0.000615	CcSEcCtD
Cycloserine—Headache—Triamcinolone—hematologic cancer	0.000391	0.000612	CcSEcCtD
Cycloserine—Confusional state—Epirubicin—hematologic cancer	0.000388	0.000608	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—EP300—hematologic cancer	0.000381	0.00166	CbGpPWpGaD
Cycloserine—Convulsion—Doxorubicin—hematologic cancer	0.000378	0.000593	CcSEcCtD
Cycloserine—Paraesthesia—Methotrexate—hematologic cancer	0.00037	0.000579	CcSEcCtD
Cycloserine—DDC—Metabolism—MTAP—hematologic cancer	0.000369	0.00161	CbGpPWpGaD
Cycloserine—Somnolence—Methotrexate—hematologic cancer	0.000366	0.000573	CcSEcCtD
Cycloserine—Hypersensitivity—Prednisone—hematologic cancer	0.000363	0.000568	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	0.000361	0.00157	CbGpPWpGaD
Cycloserine—Confusional state—Doxorubicin—hematologic cancer	0.000359	0.000563	CcSEcCtD
Cycloserine—Rash—Dexamethasone—hematologic cancer	0.000357	0.000559	CcSEcCtD
Cycloserine—Rash—Betamethasone—hematologic cancer	0.000357	0.000559	CcSEcCtD
Cycloserine—Dermatitis—Betamethasone—hematologic cancer	0.000356	0.000558	CcSEcCtD
Cycloserine—Dermatitis—Dexamethasone—hematologic cancer	0.000356	0.000558	CcSEcCtD
Cycloserine—Headache—Betamethasone—hematologic cancer	0.000354	0.000555	CcSEcCtD
Cycloserine—Headache—Dexamethasone—hematologic cancer	0.000354	0.000555	CcSEcCtD
Cycloserine—Paraesthesia—Epirubicin—hematologic cancer	0.000346	0.000542	CcSEcCtD
Cycloserine—Somnolence—Epirubicin—hematologic cancer	0.000342	0.000536	CcSEcCtD
Cycloserine—Feeling abnormal—Methotrexate—hematologic cancer	0.000339	0.000531	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—JUN—hematologic cancer	0.000337	0.00147	CbGpPWpGaD
Cycloserine—DDC—Metabolism—FHL2—hematologic cancer	0.000329	0.00144	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PTEN—hematologic cancer	0.000326	0.00142	CbGpPWpGaD
Cycloserine—DDC—Metabolism—AGRN—hematologic cancer	0.000323	0.00141	CbGpPWpGaD
Cycloserine—Paraesthesia—Doxorubicin—hematologic cancer	0.00032	0.000501	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—MAPK8—hematologic cancer	0.000319	0.00139	CbGpPWpGaD
Cycloserine—Feeling abnormal—Epirubicin—hematologic cancer	0.000317	0.000497	CcSEcCtD
Cycloserine—Somnolence—Doxorubicin—hematologic cancer	0.000317	0.000496	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—EP300—hematologic cancer	0.000311	0.00136	CbGpPWpGaD
Cycloserine—Rash—Prednisone—hematologic cancer	0.000311	0.000486	CcSEcCtD
Cycloserine—Dermatitis—Prednisone—hematologic cancer	0.00031	0.000486	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—TNF—hematologic cancer	0.000309	0.00135	CbGpPWpGaD
Cycloserine—Headache—Prednisone—hematologic cancer	0.000309	0.000483	CcSEcCtD
Cycloserine—DDC—Metabolism—HMMR—hematologic cancer	0.000306	0.00134	CbGpPWpGaD
Cycloserine—DDC—Metabolism—IDH2—hematologic cancer	0.000306	0.00134	CbGpPWpGaD
Cycloserine—Hypersensitivity—Methotrexate—hematologic cancer	0.000303	0.000475	CcSEcCtD
Cycloserine—Feeling abnormal—Doxorubicin—hematologic cancer	0.000294	0.00046	CcSEcCtD
Cycloserine—DDC—Metabolism—ARNTL—hematologic cancer	0.000288	0.00126	CbGpPWpGaD
Cycloserine—Hypersensitivity—Epirubicin—hematologic cancer	0.000284	0.000445	CcSEcCtD
Cycloserine—DDC—Metabolism—ACP5—hematologic cancer	0.00028	0.00122	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CA9—hematologic cancer	0.00028	0.00122	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NCOR2—hematologic cancer	0.000276	0.00121	CbGpPWpGaD
Cycloserine—DDC—Metabolism—IDH1—hematologic cancer	0.000263	0.00115	CbGpPWpGaD
Cycloserine—Hypersensitivity—Doxorubicin—hematologic cancer	0.000263	0.000411	CcSEcCtD
Cycloserine—DDC—Metabolism—GSTO1—hematologic cancer	0.00026	0.00114	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCC3—hematologic cancer	0.00026	0.00114	CbGpPWpGaD
Cycloserine—DDC—Metabolism—TXN—hematologic cancer	0.00026	0.00114	CbGpPWpGaD
Cycloserine—Rash—Methotrexate—hematologic cancer	0.00026	0.000407	CcSEcCtD
Cycloserine—Dermatitis—Methotrexate—hematologic cancer	0.000259	0.000406	CcSEcCtD
Cycloserine—Headache—Methotrexate—hematologic cancer	0.000258	0.000404	CcSEcCtD
Cycloserine—DDC—Metabolism—SPHK1—hematologic cancer	0.000255	0.00111	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL6—hematologic cancer	0.00025	0.00109	CbGpPWpGaD
Cycloserine—DDC—Metabolism—UGT1A1—hematologic cancer	0.000245	0.00107	CbGpPWpGaD
Cycloserine—Rash—Epirubicin—hematologic cancer	0.000243	0.00038	CcSEcCtD
Cycloserine—Dermatitis—Epirubicin—hematologic cancer	0.000243	0.00038	CcSEcCtD
Cycloserine—Headache—Epirubicin—hematologic cancer	0.000241	0.000378	CcSEcCtD
Cycloserine—DDC—Metabolism—SLC22A1—hematologic cancer	0.000238	0.00104	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CRABP1—hematologic cancer	0.000238	0.00104	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALOX5—hematologic cancer	0.000232	0.00101	CbGpPWpGaD
Cycloserine—Rash—Doxorubicin—hematologic cancer	0.000225	0.000352	CcSEcCtD
Cycloserine—DDC—Metabolism—NUP98—hematologic cancer	0.000225	0.00098	CbGpPWpGaD
Cycloserine—Dermatitis—Doxorubicin—hematologic cancer	0.000225	0.000352	CcSEcCtD
Cycloserine—Headache—Doxorubicin—hematologic cancer	0.000223	0.00035	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—TP53—hematologic cancer	0.000223	0.000971	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ADCY7—hematologic cancer	0.000218	0.000951	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NCOA3—hematologic cancer	0.000218	0.000951	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NUP214—hematologic cancer	0.000217	0.000945	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MTR—hematologic cancer	0.000212	0.000926	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCG2—hematologic cancer	0.000212	0.000926	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ENO2—hematologic cancer	0.000208	0.000908	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—IL6—hematologic cancer	0.000204	0.000889	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTT1—hematologic cancer	0.000202	0.00088	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SDC1—hematologic cancer	0.000197	0.00086	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CD44—hematologic cancer	0.000168	0.000732	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NQO1—hematologic cancer	0.000168	0.000732	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYCS—hematologic cancer	0.000159	0.000692	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HSP90AA1—hematologic cancer	0.000158	0.000688	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTP1—hematologic cancer	0.00014	0.00061	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCB1—hematologic cancer	0.000132	0.000578	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTM1—hematologic cancer	0.000129	0.000561	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NCOR1—hematologic cancer	0.000129	0.000561	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MTHFR—hematologic cancer	0.000114	0.000496	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CG—hematologic cancer	9.55e-05	0.000416	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CREBBP—hematologic cancer	8.85e-05	0.000386	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CD—hematologic cancer	8.39e-05	0.000366	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALB—hematologic cancer	8.29e-05	0.000361	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3R1—hematologic cancer	7.93e-05	0.000346	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CB—hematologic cancer	7.32e-05	0.000319	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTEN—hematologic cancer	6.32e-05	0.000276	CbGpPWpGaD
Cycloserine—DDC—Metabolism—EP300—hematologic cancer	6.03e-05	0.000263	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CA—hematologic cancer	4.46e-05	0.000194	CbGpPWpGaD
Cycloserine—DDC—Metabolism—AKT1—hematologic cancer	3.64e-05	0.000159	CbGpPWpGaD
